Ampyra’s worth, being questioned by an insurance carrier

Stuart SchlossmanAlternative therapies and devices for Multiple Sclerosis (MS)

Last week  I posted information regarding AETNA insurance company’s decision to stop paying for an MS Medication. I also mentioned that if we did not stop this from happening that other companies might begin doing the same thing… And today I read this:

Acorda
sinks after insurance provider questions MS drug


Theflyonthewall.com via Yahoo! Finance
Mon, 08 Oct 2012 08:41 AM PDT




Acorda Therapeutics (ACOR) is retreating after Group Health, which provides
health insurance to over 600,000 people in the Northwest, questioned the
necessity of the company’s multiple sclerosis treatment,
… 

THIS IS B.S.  everybody and we need to Voice our concerns.


IF the FDA approved the medications, then they must have found worth in the drug(s)

Click here to read the blog posting about Aetna and Then, Call Aetna to voice your resentment to their decision. The phone numbers are found at that posting.

..

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews